The Health Department is offering a limited competition grant for the Strategic Timing of Antiretroviral Treatment (START) trial. This grant aims to support the completion of a randomized clinical trial investigating the effectiveness of immediate initiation of antiretroviral treatment (ART) in HIV-positive patients to delay the occurrence of AIDS, non-AIDS events, and death. The closing date for applications is November 19, 2014.
Opportunity ID: 263508
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-14-329 |
| Funding Opportunity Title: | Limited Competition: Strategic Timing of Antiretroviral Treatment (START) (UM1) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 29, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Nov 19, 2014 |
| Current Closing Date for Applications: | Nov 19, 2014 |
| Archive Date: | Dec 20, 2014 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Only the current START awardee is eligible to apply to this limited competition FOA. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this limited competition Funding Opportunity Announcement (FOA) is to continue support to complete the Strategic Timing of Antiretroviral Treatment (START) trial. START is a randomized clinical trial to determine if immediate initiation of antiretroviral treatment (ART) in HIV-positive patients is superior in delaying the occurrence of AIDS, non-AIDS events and death. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-14-329.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | FORMS-C | PKG00204683 | Oct 19, 2014 | Nov 19, 2014 | View |
Package 1
Mandatory forms
263508 RR_SF424_2_0-2.0.pdf
263508 PHS398_ResearchPlan_2_0-2.0.pdf
263508 PHS398_CoverPageSupplement_2_0-2.0.pdf
263508 RR_Budget_1_3-1.3.pdf
263508 RR_KeyPersonExpanded_2_0-2.0.pdf
263508 RR_OtherProjectInfo_1_3-1.3.pdf
263508 PerformanceSite_2_0-2.0.pdf
Optional forms
263508 PlannedReport-1.0.pdf
263508 PHS398_CumulativeInclusionReport-1.0.pdf
263508 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
